May 23, 2012

Top Atrial Fibrillation (Afib) Articles of 2011

Share on Twitter
Share via emailSubmit to StumbleUpon

In follow up to our announcement yesterday of the Top Ten Atrial Fibrillation Videos of 2011, StopAfib.org now unveils the Top Ten Atrial Fibrillation Articles of 2011. Major topics of interest to the atrial fibrillation patient community this year were afib stroke prevention and the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for [...]

Share on Twitter
Share via emailSubmit to StumbleUpon

What Everyone with Atrial Fibrillation Should Know about Multaq (dronedarone)

Share on Twitter
Share via emailSubmit to StumbleUpon

As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits [...]

Share on Twitter
Share via emailSubmit to StumbleUpon

Atrial Fibrillation Antiarrhythmic Drugs–StopAfib.org interviews Prof. John Camm

Share on Twitter
Share via emailSubmit to StumbleUpon

In this video from Boston Atrial Fibrillation Symposium 2010, Professor John Camm discusses the two newest antiarrhythmic drugs, dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away. These antiarrhythmic (rhythm control) drugs help to put patients

Share on Twitter
Share via emailSubmit to StumbleUpon

Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation – Video

Share on Twitter
Share via emailSubmit to StumbleUpon

At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial [...]

Share on Twitter
Share via emailSubmit to StumbleUpon

StopAfib.org applauds FDA approval of Multaq® (dronedarone), a safer option to amiodarone for atrial fibrillation (afib) patients

Share on Twitter
Share via emailSubmit to StumbleUpon

We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I’ve fielded has been “When will Multaq® be available?” That happened this week, and the excitement they have shared [...]

Share on Twitter
Share via emailSubmit to StumbleUpon

FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

Share on Twitter
Share via emailSubmit to StumbleUpon

BREAKING NEWS Multaq(R), the much anticipated replacement for amiodarone, just received FDA approval. Read the press release: FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

Share on Twitter
Share via emailSubmit to StumbleUpon

Amiodarone Replacement Gets the Fast Track

Share on Twitter
Share via emailSubmit to StumbleUpon

For those atrial fibrillation patients who are on amiodarone, or for those avoiding it, there is good news. Multaq® (dronedarone), a replacement for amiodarone, received priority review status from the US FDA. While amiodarone is among the most effective atrial fibrillation medications, it has major toxicity issues that dronedarone doesn’t display. Read more…

Share on Twitter
Share via emailSubmit to StumbleUpon